Rise In Cancer Cases Is Driving The Global Biopsy Device Market To Grow At 6.82% Of Cagr By 2027

Triton Market Research presents their Global Biopsy device market report segmented by device type (breast biopsy, gastrointestinal (GI) biopsy, soft tissue biopsy needles, bronchial biopsy, gynecological biopsy device, robotic guidance system and other devices), by therapeutic areas ( breast biopsy, GI biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy and other therapeutic area), by display technologies (MRI guided biopsy, stereotactic guided biopsy, ultrasound-guided biopsy, CT guided biopsy and other display technologies), by end-users (diagnosis center and hospitals), and by geographical region (North America, Europe, Asia Pacific, and rest of the world) - discussing Industry Value Chain Analysis, Porter's 5 Force Analysis, Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2019-2027).

Triton Market Research expects the global biopsy device market to witness a compound annual growth rate of 6.82% during the forecast period of 2019-2027. The market growth is being propelled by the global increase in cancer cases, growing elderly population and the rise in the awareness of these devices.

The MRI guided biopsies are at the forefront of display technologies associated with the biopsy device market. This segment uses a powerful magnetic field, radio waves and a computer to help locate any abnormality and guide a needle to remove a tissue sample for examination under a microscope. Majority of the breast biopsies are performed using MRI guided biopsies. Diagnostic ceters are the major end-user industries for this market. Sites like skin, breast, bone marrow, GI tract, liver, lung, bladder, colon and lymph nodes are biopsied at these centers. The use of novel techniques like vacuum-assisted biopsies is expected to propel the market growth in the coming years.

The Asia-Pacific is anticipated to be the most promising region over the forecast period. The region offers a large patient pool of elderly population and a large number of cases for chronic diseases like cancers. The high market share for biopsy devices is expected from Japan and China in the Asia-Pacific region. The other geographies analyzed in this report include Europe and North America. The North American region presently contributes a major share to the global market. It is chiefly driven by the favourable reimbursement policies in countries like U.S and Canada.

In this report, Triton Market Research provides a detailed profiling of key companies operating in the biopsy device market like Becton and Dickinson, B. Braun Melsungen Ag, Argon Medical Devices Inc., Planmeca Oy, Cardinal Health Inc., Ad-Tech Medical Instrument Corp, Qiagen N.V, I.M.S. Internazionale Medico Scientifica Srl, C. R. Bard, Inc. and Boston Scientific Corporation.